Ischemia-reperfusion injury: molecular mechanisms and therapeutic targets
2024 · Signal Transduction and Targeted Therapy · 514 citations
https://doi.org/10.1038/s41392-023-01688-x
H
Hui Meng
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
153
Papers
2.7K
Citations
25
h-index
35
i10-index
Hui Meng is an academic researcher from Central South University. The author has contributed to research in topics: Prostate Cancer Treatment and Research & Legal and Regulatory Analysis & Wood and Agarwood Research. The author has an h-index of 25, co-authored 131 publications.
ORCID: 0000-0002-8264-2992Papers by this author
worksRole of the dynamic tumor microenvironment in controversies regarding immune checkpoint inhibitors for the treatment of non-small cell lung cancer (NSCLC) with EGFR mutations
2019 · Molecular Cancer · 289 citations
https://doi.org/10.1186/s12943-019-1062-7
ZG16 regulates PD-L1 expression and promotes local immunity in colon cancer
2020 · Translational Oncology · 43 citations
https://doi.org/10.1016/j.tranon.2020.101003
Selection and Validation of Reference Genes for Gene Expression Studies by RT-PCR in Dalbergia odorifera
2019 · Scientific Reports · 23 citations
https://doi.org/10.1038/s41598-019-39088-3
Dalbergia odorifera Trans-Nerolidol Protects Against Myocardial Ischemia via Downregulating Cytochrome- and Caspases-Signaling Pathways in Isoproterenol-Induced Rats
2025 · International Journal of Molecular Sciences · 6 citations
https://doi.org/10.3390/ijms26052251
Efficacy and safety of selective internal radiotherapy versus sorafenib for intermediate-locally advanced hepatocellular carcinoma: a systematic review and meta-analysis
2019 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.7594001
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat